Northpond Ventures III GP, LLC bought KYTX
February 12, 2024 · Form 4 insider transaction
Northpond Ventures III GP, LLC bought 450,000 shares of Kyverna Therapeutics, Inc. at $22.00 per share, a transaction worth $9.90M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
450,000
Price
$22.00
Total value
$9.90M
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateFebruary 12, 2024
Filing dateFebruary 12, 2024
Shares owned after450,000
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Northpond Ventures GP, LLC ("Northpond LLC") is the general partner of Northpond Ventures, LP ("Northpond Fund"), and Michael P. Rubin is the managing member of Northpond LLC. As a result, Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund. Mr. Rubin disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any.